Format

Send to

Choose Destination
Circ Res. 2011 Sep 16;109(7):807-20. doi: 10.1161/CIRCRESAHA.110.230995.

Cardiovascular pharmacogenomics.

Author information

1
Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-0575, USA. dan.roden@vanderbilt.edu

Abstract

Patients vary in their responses to drug therapy, and some of that variability is genetically determined. This review outlines general approaches used to identify genetic variation that influences drug response. Examples from specific therapeutic areas are presented, such as cholesterol management, arrhythmias, heart failure, hypertension, warfarin anticoagulation, and antiplatelet agents. A brief view of potential pathways to implementation is presented.

PMID:
21921273
PMCID:
PMC3201825
DOI:
10.1161/CIRCRESAHA.110.230995
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center